ArticleNPJ precision oncology2018

A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia.

A Ljungars et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.